In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates
Abstract Background Recently, Mycobacterium avium complex (MAC) infections have been increasing, especially in immunocompromised and older adults. The rapid increase has triggered a global health concern due to limited therapeutic strategies and adverse effects caused by long-term medication. To pro...
Main Authors: | Siran Lin, Wenya Hua, Shiyong Wang, Yu Zhang, Xinchang Chen, Hong Liu, Lingyun Shao, Jiazhen Chen, Wenhong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12866-022-02582-2 |
Similar Items
-
Treatment of Mycobacterium avium Complex Pulmonary Disease
by: Yong-Soo Kwon, M.D., et al.
Published: (2019-01-01) -
Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
by: Eduardo Marfil, et al.
Published: (2022-09-01) -
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium–intracellulare complex subspecies and antimicrobial susceptibility
by: Chia-Ling Chang, et al.
Published: (2020-09-01) -
A case of isolated pulmonary Mycobacterium avium complex infection in an immunocompetent host
by: Sivanthi Sapna Rajendran, et al.
Published: (2023-01-01) -
Proctitis Caused by Mycobacterium avium-intracellulare in an HIV-Infected Patient
by: Jose Armando Gonzales Zamora, et al.
Published: (2018-05-01)